[OPRD1 gene polymorphism (rs4654327) as a potential predictor of the effectiveness of long-acting naltrexone in patients with alcohol addiction].
- DOI
- 10.17116/jnevro202612604156
- Published
- 2026
- Container
- Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.17116/jnevro202612604156,
title = {[OPRD1 gene polymorphism (rs4654327) as a potential predictor of the effectiveness of long-acting naltrexone in patients with alcohol addiction].},
author = {Miroshkin SS and Skryabin VY and Shipitsyn VV and Masyakin AV},
year = {2026},
journal = {Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova},
doi = {10.17116/jnevro202612604156},
url = {https://doi.org/10.17116/jnevro202612604156}
}RIS
TY - JOUR TI - [OPRD1 gene polymorphism (rs4654327) as a potential predictor of the effectiveness of long-acting naltrexone in patients with alcohol addiction]. AU - Miroshkin SS AU - Skryabin VY AU - Shipitsyn VV AU - Masyakin AV PY - 2026 JO - Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova DO - 10.17116/jnevro202612604156 UR - https://doi.org/10.17116/jnevro202612604156 ER -
APA
SS, M., VY, S., VV, S., & AV, M. (2026). [OPRD1 gene polymorphism (rs4654327) as a potential predictor of the effectiveness of long-acting naltrexone in patients with alcohol addiction].. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. https://doi.org/10.17116/jnevro202612604156
Source records
- pubmed · retrieved 2026-09-26T02:30:30.663Z
- europe-pmc · retrieved 2026-09-26T02:30:30.663Z